Work

Supplementary Figure 3 from Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma

Year: 2023

Type: supplementary-materials

Abstract: YEST348I expression rescues Dasatinib treatment in aRMS cells.

DOI: 10.1158/0008-5472.22422948

Authors: Katherine K. Slemmons, Choh Yeung, Joshua T. Baumgart, Jhazeel O. Martinez Juarez, Amy McCalla, Lee J. Helman

Language: English

Topic: Hippo pathway signaling and YAP/TAZ

Subfield: Cell Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362363175

Cites:

Cited by:

Related to: 10